Trials / Recruiting
RecruitingNCT06633289
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy
Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 67 (estimated)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 60 Days – 3 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether a new hydrolyzed rice protein-based formula is hypoallergenic in infants and young children with documented Immunoglobulin E (IgE)-mediated Cow Milk Protein Allergy (CMPA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental formula | New hydrolyzed rice protein-based formula |
| OTHER | Control formula | Commercially available amino acid-based formula. |
Timeline
- Start date
- 2024-11-05
- Primary completion
- 2026-09-01
- Completion
- 2026-10-01
- First posted
- 2024-10-09
- Last updated
- 2025-07-01
Locations
11 sites across 3 countries: Germany, Italy, Poland
Source: ClinicalTrials.gov record NCT06633289. Inclusion in this directory is not an endorsement.